Mandate

Vinge advises Bergs Timber in connection with transfer of Berg’s Swedish sawmill business

Vinge has advised Bergs Timber AB (publ) in connection with the transfer of the sawmills in Orrefors, Vimmerby, Mörlunda and the assets at the already discontinued operations at Gransjö.

The consideration for the operations, including the working capital involved, is estimated to amount to approximately SEK 400 million, of which SEK 303 million pertains to fixed assets. Bergs Timber has sales of approximately SEK 3.2 billion and is listed on Nasdaq Stockholm.

Vinge’s team has primarily consisted of Jesper Schönbeck, Ulrich Ziche, Joel Wahlberg, Joel Magnusson, Mikaela Falkner, Falkner, Louise Brorsson Salomon, Trine Osen Bergqvist, Kristoffer Larson and Jessica Öijer.

 

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026